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Hypoxia Inducible Factor-Stabilizing Bioactive Glasses
for Directing Mesenchymal Stem Cell Behavior
Maria M. Azevedo, PhD,1,2 Olga Tsigkou, PhD,1,2 Rekha Nair, PhD,1–3 Julian R. Jones, PhD,1
Gavin Jell, PhD,1,3 and Molly M. Stevens, PhD1,2,4
Oxygen tension is a known regulator of mesenchymal stem cell (MSC) plasticity, differentiation, proliferation,
and recruitment to sites of injury. Materials capable of affecting the MSC oxygen-sensing pathway, indepen-
dently of the environmental oxygen pressure, are therefore of immense interest to the tissue engineering (TE)
and regenerative medicine community. In this study, we describe the evaluation of the effect of hypoxia
inducible factor (HIF)-stabilizing bioactive glasses (BGs) on human MSCs. The dissolution products from these
hypoxia-mimicking BGs stabilized HIF-1a in a concentration-dependent manner, altered cell proliferation and
metabolism, and upregulated a number of genes involved in the hypoxic response (HIF1A, HIF2A, and VHL),
MSC survival (SAG and BCL2), extracellular matrix remodeling (MMP1), and angiogenesis (VEGF and
PDGF). These HIF-stabilizing materials can therefore be used to improve MSC survival and enhance regen-
eration in a number of TE strategies.
Introduction
Mesenchymal stem cells (MSCs) have an importantrole in tissue regeneration in vivo1,2 and have been
used extensively in a number of cell therapy and tissue
engineering (TE) strategies.3,4 Their differentiation capa-
bility, immunomodulatory activity, and ability to be re-
cruited to sites of injury are the main characteristics that
together suggest these cells can act as a ‘‘natural in vivo
system for tissue repair.’’4
Oxygen pressure (pO2) is a known regulator of the be-
havior of several stem/progenitor cells, including MSCs.5,6
The physiological pO2 value in bone marrow has been es-
timated to vary from 1% to 7%, with well-oxygenated
marrow sinuses and more hypoxic endosteal regions.7 At the
commonly used in vitro pO2 of 21%, MSCs have diminished
growth potential and typically become senescent after a few
passages.8 For this reason, the effect of pO2 on ex vivo
expansion of MSCs has been extensively studied. When
MSCs are expanded under hypoxia (1–3% pO2), their life-
span was extended and senescence was avoided.8,9 In ad-
dition, a low pO2 value has been shown to maintain MSCs in
an undifferentiated state9–11 as well as to increase the pop-
ulation homogeneity.12 Interestingly, hypoxia also stimu-
lates the angiogenic properties of MSCs. Migration of these
multipotent cells in vitro as well as tropism to sites of injury
in vivo have been described.13–15 The matrix metallopro-
teinase (MMP) activity and endothelial cell tubule forma-
tion ability were enhanced as MSCs were cultured in vitro at
pO2 values of lower than 3%.
16,17 Mechanistically, hypoxia
is known to enhance the stabilization and activity of the
hypoxia-sensing transcription factor, hypoxia inducible
factor 1 alpha (HIF-1a).18 In MSCs, the HIF-1a activity
induces expression of a plethora of proangiogenic factors
such as VEGF, HGF, and FGF2.9,13,16,19–21 Hypoxia induces
these processes through autocrine and paracrine effects
following protein secretion. In most cases, HIF-1a stabili-
zation has been shown to be an essential factor and a se-
quential contributor, making HIF-1a a target for regulation
by materials for regenerative therapies.
An expanding palette of small molecules and ions is,
currently, widely used for the activation of cellular re-
sponses.22 The most well-described example in the field of
TE is through the use of bioactive glass (BG). The release of
both calcium and soluble sı´lica from the glass has been
shown to facilitate bone regeneration, by upregulating ex-
pression of genes involved in pathways essential for osteo-
blast differentiation.23 More recently, we have shown that
strontium can positively impact bone repair, promoting os-
teoblast activity and reducing osteoclast survival.24 Com-
pared to growth factor release, the main advantages of using
ions for TE purposes lie not only on the cost but, more
importantly, also on the fact that their release can be easily
controlled and a single ion, contrarily to single growth
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factors, can activate specific cellular responses that would
require a plethora of growth factors to be delivered in a very
precise manner.25 Moreover, the activity of growth factors is
limited by their half-life within the body as well as the
narrow concentration range within which the response they
activate is not aberrant.
We have previously described the development of a series
of hypoxia-mimicking BGs.26 These glasses enable the
controlled release of cobalt ions (Co2 + ) (Fig. 1), a cation
known to activate the hypoxia pathway through inhibition of
HIF-1a degradation.18,27 Making use of this strategy, we
intend to stabilize the hypoxia-sensing transcription factor,
which will subsequently activate a variety of genes crucial for
regeneration, regardless of the local environmental oxygen
pressure. In this study, the effect of hypoxia-mimicking
BGs on the biology and behavior of human MSCs (hMSCs)
was assessed. hMSCs were treated with hypoxia-mimicking
BG-conditioned media, after which the activity of the hyp-
oxia pathway, cell viability, and proliferation were evalu-
ated. To better understand the biological effect of the BG, an
array of known hypoxia-regulated genes was assessed.
Materials and Methods
Cell culture
hMSCs were purchased from Cambrex. They were ex-
panded in low glucose Dulbecco’s modified Eagle’s me-
dium (DMEM; Gibco) supplemented with 10% (v/v) fetal
bovine serum (Gibco), and 50 U/mL penicillin, and 50 mg/
mL streptomycin (Gibco). Initial culture was performed in
75-cm2 flasks at 37C in a humidified atmosphere with 5%
CO2, and the medium was changed every 2–3 days. Ex-
periments were performed using cells at passage 5–8.
hMSCs were treated for different lengths of time with BG-
conditioned media. The medium containing CoCl2 was used
as a positive control for cobalt ions.
Preparation of BG-conditioned media
BGs were manufactured, as previously described,26 with
compositions, as listed in Table 1. The glass frit was ground
and sieved to less than 38mm. BGs were named BG0Co,
BG0.5Co, BG1Co, BG2Co, and BG4Co, as they contained,
respectively, 0, 0.5, 1, 2, and 4 mol% of Co2 + in their
composition. BG-conditioned media were prepared by in-
cubating BG particles ( < 38 mm) in DMEM at a concentra-
tion of 1.5 mg/mL, with continuous rolling, for 4 h at 37C,
followed by filtration (0.2-mm-pore filters). To stabilize pH,
conditioned media were incubated (37C, 5% CO2) in a
vented flask for 2 h before use. The concentration of the ions
released from the BG to the conditioned media was deter-
mined by inductively coupled plasma optical emission
spectrometry (ICP-OES) (Table 2). A control CoCl2-con-
taining medium was prepared with a final Co2 + concentra-
tion of 100mM. The Co2 + concentration was confirmed by
ICP-OES (Table 2).
Evaluation of ion release from BGs
The prepared BG samples ( < 38 mm particles) were in-
cubated in DMEM (45 mg of glass per 50 cm - 3 DMEM) at
37C, in an orbital shaker at 120 rpm. After 4 h, 5 cm - 3
samples were collected, centrifuged, and filtered. ICP-OES
was performed on the resulting solutions, and the concen-
trations of silicon, calcium, sodium, phosphorus, and cobalt
were calculated, based on standard solutions. ICP was per-
formed using a Thermo Scientific iCAP 6000 Series ICP
Spectrometer and each sample read in triplicate.
AlamarBlue assay
To determine cell viability, hMSCs were seeded in 96-
well plates (50,000 cells/cm2) in BG-conditioned media.
After 2, 4, or 7 days, the cell culture medium was replaced
with 150 mL of 10% (v/v) alamarBlue in DMEM with no
phenol red (Gibco). After a 2-h incubation at 37C, 100mL
of the reaction product was transferred to a black 96-well
plate to measure fluorescence at an excitation wavelength of
540 nm and an emission wavelength of 585 nm in a micro-
plate reader (SpectraMax M5; Molecular Devices).
FIG. 1. The structure of bioactive glasses (BGs) is based
on SiO4 tetrahedral network (as described previously
26), in
which the 3D continuous network is formed by SiO4 tetra-
hedral connected to each other by oxygen atoms in the
corners. The addition of alkali and alkali-earth oxides (e.g.,
CaO, Na2O, and CoO) reduces the degree of connectivity of
the network, which facilitates the degradation of the glass
structure when immersed in aqueous solutions or in body
fluids. Varying the type and concentration of alkali and al-
kali-earth oxides added to the glass structure enables the
controlled release of cations of interest. The lines represent
network forming-like bonding and broken lines represent
network modifying bonding. Color images available online
at www.liebertpub.com/tea
Table 1. Composition of the Bioactive Glass
Used in This Study
BGs
SiO2
(mol%)
P2O5
(mol%)
CaO
(mol%)
Na2O
(mol%)
CoO
(mol%)
BG0Co 49.46 1.07 23.08 26.38
BG0.5Co 49.46 1.07 22.58 26.38 0.50
BG1Co 49.46 1.07 22.08 26.38 1.00
BG2Co 49.46 1.07 21.08 26.38 2.00
BG4Co 49.46 1.07 19.08 26.38 4.00
BG, bioactive glass.
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Lactate dehydrogenase assay
The colorimetric lactate dehydrogenase (LDH) assay
(CytoTox 96 Non-Radioactive Cytotoxicity Assay; Prome-
ga) was performed to assess the effect of BG-conditioned
medium on hMSC metabolism. hMSCs were seeded in 96-
well plates (50,000 cells/cm2) in BG-conditioned media.
After 2, 4, or 7 days, adherent cells were lysed. Fifty mi-
croliters of reconstituted substrate mix was added to 50mL
of the cell lysate and incubated for 30 min. The reaction was
stopped with 50 mL of stop solution, and absorbance was
read at 490 nm in a microplate reader (SpectraMax M5;
Molecular Devices). The LDH activity was normalized to
total DNA content that was determined using the Hoechst
staining method.
HIF-1a activity assay
The TransAM HIF-1 assay kit (Active Motif) was used to
assess the HIF-1a activity. hMSCs were seeded (50,000
cells/cm2) in 25-cm2 flasks and cultured until they were
*90% confluent. Cells were then incubated for 8 h in BG-
conditioned media and the assay was performed according
to the manufacturer’s instructions. Briefly, nuclear extracts
were prepared and 8 mg was added to a 96-well plate pre-
coated with hypoxia-responsive element-specific oligonu-
cleotides. A primary antibody specific for the bound and
active form of the transcription factor was then added, fol-
lowed by incubation with a secondary antibody conjugated
to horseradish peroxidase and a substrate solution. Absor-
bance was measured in a microplate reader (SpectraMax
M5; Molecular Devices) at a wavelength of 450 nm and a
reference wavelength of 655 nm.
Human HIF-regulated cDNA profiling
The effect on human HIF-regulated cDNA was performed
using a human HIF-regulated cDNA profiling kit from
Signosis. hMSCs were seeded (50,000 cells/cm2) in 25-cm2
flasks and cultured until they were *90% confluent. Cells
were then incubated for 24 h in BG-conditioned media and
the assay was performed according to the manufacturer’s
instructions. Briefly, cellular lysates were prepared using the
lysis buffer provided, and cDNA synthesis was performed.
The plate hybridization was performed using the cDNA
prepared in combination with the provided buffer. After
overnight incubation at 45C, the plate was washed and a
streptavidin-HRP conjugate was added. The detection was
performed after addition of the substrate solution using a
luminescence microplate reader (SpectraMax M5; Mole-
cular Devices).
Analysis of VEGF expression
A VEGF-A165 ELISA kit (Quantikine Human VEGF
immunoassay; R&D Systems) was performed to assess
VEGF-A165 secretion. hMSCs were seeded in 24-well
plates (50,000 cells/cm2) in BG-conditioned media. After 2,
4, or 7 days, the cell culture supernatant was collected and
the VEGF concentration determined. Briefly, cell culture
supernatant samples or standards together with assay diluent
were added to the provided 96-well plate (precoated with a
monoclonal antibody specific for VEGF-A165). An en-
zyme-linked polyclonal antibody specific for VEGF was
then added to the wells, followed by a substrate solution.
Absorbance was measured in a microplate reader (Spec-
traMax M5; Molecular Devices) at 450 nm with a reference
wavelength of 540 nm.
Statistical analysis
All experimental data shown are expressed as mean – SD
and were obtained from experiments performed at least
twice in quadruplicates. All data analysis was performed in
Excel. Statistical analysis was by one-way analysis of var-
iance using multiple comparisons (Bonferroni test) using
SPSS, with p-values < 0.05 considered significant.
Results
Low pO2 or hypoxia affects MSC metabolism, prolifer-
ation, differentiation, and survival.28 Although Co2 + has
been shown to activate the hypoxia pathway,29,30 its effect
on the biology of hMSCs is incompletely characterized. In
this study, hypoxia-mimicking BGs that release Co2 + are
investigated for their effect on hMSC proliferation, metab-
olism, and activation of the hypoxia pathway.
Effect of the hypoxia-mimicking BGs on hMSC viability
An alamarBlue assay was used to assess the viability and
metabolic activity of hMSCs after exposure to the hypoxia-
mimicking BGs (Table 1) after 2, 4, and 7 days (Fig. 2). Up to 4
days, there was no significant difference in the viability/met-
abolic activity of hMSCs treated with either BG-conditioned
Table 2. Elemental Concentrations of the Ionic Dissolution Products of the BG (Si, Ca, Na, P, Co)
in the BG-Conditioned DMEM (ppm) Determined by ICP-OES
Si (g$L- 1) Ca (g$L - 1) Na (g$L - 1) P (g$L - 1) Co (g$L - 1) Co (lM)
DMEM 0.0 – 0.2 81.3– 6.6 2920 – 420 39.1 – 3.0 0.03– 0.05 0.51 – 0.85
BG0Co 73.7 – 13.0 95.7– 27.2 3047 – 508 15.1 – 7.0 0.02– 0.03 0.33 – 0.51
BG0.5Co 69.3 – 6.6 103.5– 14.7 2916 – 413 19.2 – 7.6 2.18– 0.40 36.97 – 6.78
BG1Co 76.8 – 12.9 106.1– 17.1 2996 – 487 16.0 – 7.6 5.35– 0.89 90.74 – 15.09
BG2Co 76.9 – 18.1 110.3– 18.3 2993 – 489 16.8 – 9.7 10.55– 2.06 178.93 – 34.94
BG4Co 80.6 – 17.6 109.8– 17.2 2995 – 523 16.5 – 7.4 22.97– 2.06 389.57 – 34.94
CoCl2 [100mM Co] 0.0 – 0.9 81.5– 8.3 2928 – 475 38.7 – 4.0 6.61– 0.62 112.11 – 10.52
The Co concentrations presented in the shadowed column were converted to mM. The values presented here are the mean– SD of all
batches used for the experiments.
DMEM, Dulbecco’s modified Eagle’s medium; ICP-OES, inductively coupled plasma–optical emission spectrometry.
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or control media. After 7 days, the cell number increased in
correlation with the concentration of Co2+ ions present.
However, the conditioned medium with the highest Co2 +
concentration (BG4Co) had no positive effect and the cell
number was statistically similar to cells cultured in the
control medium. A medium supplemented with CoCl2
showed a similar effect to the BG1Co and BG2Co BGs,
which could be explained by the similar Co2 + concentra-
tions in these three conditions.
Effect of the hypoxia-mimicking BG
on hMSC metabolism
When cells experience hypoxia, they alter their metabo-
lism through the activation of the hypoxia pathway and the
reduction of pyruvate to lactate by LDH becomes their main
energy source.31 To assess the effect of the hypoxia-mim-
icking BGs on hMSC metabolism, the LDH activity was
measured after 2, 4, and 7 days (Fig. 3). At every time point
evaluated, the LDH activity (normalized to total DNA) was
higher in the presence of the BG-conditioned medium in a
concentration-dependent manner. Over time, the difference
between cells exposed to the BG-conditioned medium and
control medium increased even further, revealing a meta-
bolic switch that occurs when hMSCs are exposed to the
hypoxia-mimicking BG-conditioned media. Only cells ex-
posed to the BG4Co-conditioned medium did not follow this
trend, with the LDH activity significantly decreased as
hMSCs were treated with the dissolution products of the BG
with the highest Co2 + concentration, suggesting toxicity at
high concentrations. The LDH activity of the cells treated
with the CoCl2-supplemented media was similar to that of
cells treated with the BG1Co- and BG2Co-conditioned
media, which can be explained by similar Co2 + concen-
trations (Table 2). At days 4 and 7, BG with no Co2 + was
also able to enhance the LDH activity, although to a lower
degree, suggesting a small effect due to the release of other
BG ions (e.g., Ca2 + ).
Effect of hypoxia-mimicking BG on the activation
of the hypoxia pathway
The HIF-1 pathway is the main regulator of the cellular
response to hypoxia. In particular, HIF-1a is activated by
translocation to the nucleus in response to low pO2, after
which it initiates the subsequent cellular responses. To de-
termine whether the hypoxia-mimicking BGs were activat-
ing, the hypoxia pathway nuclear HIF-1a was quantified by
ELISA. The HIF-1a activity was significantly enhanced in a
concentration-dependent manner when hMSCs were incu-
bated with the hypoxia-mimicking BG-conditioned media
(Fig. 4). BG0.5Co-conditioned media doubled the HIF-1a
activity compared to the control, while BG2Co-conditioned
media quadrupled the HIF-1a activity. The enhancement of
FIG. 2. Effect of hypoxia-mimicking BGs on hMSC via-
bility. An alamarBlue assay was performed after hMSCs
were treated with BG-conditioned media (1.5 mg/mL) for 1,
2, 4, and 7 days. (*) Indicates that the difference between the
marked bar and the control (cells cultured with standard cell
culture media, with no BG) for the same time period is
statistically significant. (U) Indicates that the difference
between the marked bar and the sample treated with the
dissolution products of BG0Co for the same time period is
statistically significant ( p< 0.05). hMSC, human mesen-
chymal stem cell.
FIG. 3. Effect of hypoxia-mimicking BGs on hMSC me-
tabolism. An LDH assay was performed after hMSCs were
treated with BG-conditioned media (1.5 mg/mL) for 2, 4, and
7 days. (*) Indicates that the difference between the marked
bar and the control (cells cultured with standard cell culture
media, with no BG) for the same time period is statistically
significant. (U) Indicates that the difference between the
marked bar and the sample treated with the dissolution
products of BG0Co for the same time period is statistically
significant ( p< 0.05). LDH, lactate dehydrogenase.
FIG. 4. Effect of hypoxia-mimicking BGs on the hypoxia
pathway: HIF-1a activity. The HIF-1a activity was deter-
mined using an immunoassay after hMSCs were treated
with BG-conditioned media (1.5 mg/mL) for 8 h. (*) In-
dicates that the difference between the marked bar and the
control (cells cultured with standard cell culture media, with
no BG) for the same time period is statistically significant.
(U) Indicates that the difference between the marked bar and
the sample treated with the dissolution products of BG0Co
for the same time period is statistically significant ( p< 0.05).
HIF-1a, hypoxia inducible factor 1 alpha.
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HIF-1a activity after exposure of hMSCs to BG4Co-con-
ditioned media was lower than when the same cells were
treated with BG1Co- and BG2Co-conditioned media, sug-
gesting toxicity due to high Co2 + concentrations.
To establish the effect of the hypoxia-mimicking BGs on
the expression of HIF-regulated genes, a gene array was
performed (Fig. 5). Several hypoxia-responsive genes, in-
cluding PDGF, PDK1, VEGF, VHL, and BCL2, were up-
regulated when hMSCs were treated with the Co2 + -
containing BGs (Fig. 5A), suggesting a global activation of
the hypoxia pathway. The upregulation of HIF1A and
HIF2A, genes directly involved in the HIF pathway, con-
firmed its activation. The upregulation of the von Hippel–
Lindau tumor suppressor factor (VHL), a protein responsible
for the degradation of HIF-1a, suggests a cellular response to
regulate the HIF pathway, although the HIF-1a activity re-
mained high (Fig. 4). Genes involved in cellular proliferation
and death (BCL2, IGF2, NDRG1, and PDGF), as well as
metabolism (SLC2A3, LEP, and PDK1) and differentiation
(BHLHB2 and NDRG1), were also upregulated, as were
several genes essential for angiogenesis, including MMP1,
MMX-1, PDGF, and VEGF. To validate the results of the
gene array at the protein level, VEGF expression was eval-
uated after hMSCs were treated with the BG-conditioned
media for 2, 4, and 7 days (Fig. 6). At every time point
assessed, VEGF expression was significantly enhanced
when cells were incubated with the hypoxia-mimicking BG-
conditioned media.
Discussion
Regulation of the hypoxia pathway is of great interest to
direct hMSC behavior to promote tissue regeneration. We
synthesized a series of BGs that could mimic the effects of
low oxygen by the controlled release of cobalt ions, which
are known to activate the hypoxia pathway through the in-
hibition of HIF-1a degradation, independently of the envi-
ronmental oxygen pressure. Using this strategy, we intend to
regulate/activate cellular responses crucial for tissue re-
generation, including cell survival, migration, and angio-
genesis, in normoxic conditions. In this study, we describe
the effect of these materials on the biological activity of
hMSCs.
The literature presents a somewhat contradictory de-
scription of how hypoxia affects hMSC viability and pro-
liferation. Some authors report no significant effect of
hypoxia on hMSC survival,21 some show growth arrest after
relatively short time periods,10 while others show increased
FIG. 5. Effect of hypoxia-
mimicking BGs on several
hypoxia-regulated genes. The
expression of several hypox-
ia-regulated genes was de-
termined using a human HIF-
regulated cDNA profiling kit
(Signosis) after hMSCs were
treated with BG-conditioned
media (1.5 mg/mL) for 24 h.
(A) Table indicating the fold
increase in expression of the
analyzed genes in compari-
son to control (no BG). (B)
Graphical representation of
the fold increase in expres-
sion of selected genes in
comparison to control (no
BG). (*) Indicates that the
difference between the
marked bar and the control
(cells cultured with standard
cell culture media, with no
BG) for the same time period
is statistically significant. (U)
Indicates that the difference
between the marked bar and
the sample treated with the
dissolution products of
BG0Co for the same time
period is statistically signifi-
cant ( p < 0.05).
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proliferation.30 Recent articles tend to agree that hypoxia
increases the lifespan of MSCs ex vivo.8,9,11 In addition,
hypoxia has been shown to upregulate genes involved in
proliferation and cell survival,17 decrease cell death, in-
crease colony forming units,9 increase culture homogenei-
ty,12 and increase the number of population doublings.8,9,11
It is thought that culturing MSCs in hypoxia better mimics
their in vivo environment in bone marrow, where the pO2 is
known to vary from 1% to 7%, which is significantly lower
than the 21% commonly used in cell culture.6 Indeed, high
pO2 increases reactive oxygen species (ROS) production,
which causes DNA damage and subsequent cell death.32
These positive effects of hypoxia are also apparent in vivo,
where MSCs expanded under hypoxic conditions in vitro
have enhanced tissue regeneration capabilities.33 For use in
TE or regenerative therapies, HIF stabilization strategies
could help overcome the limitations associated with the low
numbers of MSCs present in the adult body by increasing
their expansion and lifespan ex vivo.
In contrast, there are only a few studies on the effect of
the hypoxia-mimicking ion, Co2 + on MSC viability and
proliferation.29,30 In those studies, proliferation was shown
to decrease with exposure to the CoCl2 supplemented me-
dium. Pacary et al. suggested this result was not due to
toxicity but simply to growth arrest as expression of p21 and
PC3 mRNA (antiproliferative proteins) is enhanced and
cyclin D1 is reduced.29 The effect is probably dependent on
hypoxia levels since MSCs at very low pO2 levels (1%)
have been shown to accumulate in the G1 phase.10 Con-
versely, when these cells are incubated at higher pO2 levels
(8%), proliferation is enhanced.10 Our results corroborate
previous findings on the effect of Co2 + on MSC viability
and proliferation. hMSC viability was unaffected by the
hypoxia-mimicking BG except when the cells were treated
with the BG containing the highest Co2 + concentration (Fig.
2). Co2 + -induced toxicity has been observed with high
Co2 + concentrations and is likely due to the formation of
ROS.32 To maintain MSC viability under exposure to the
hypoxia-mimicking BGs, Co2 + levels should therefore be
accurately controlled both in terms of concentration and
duration of exposure. On the other hand, the BG0Co was
never shown to decrease cell viability, indicating that BG
with no Co2 + does not diminish the growth of hMSCs.
In normoxia, HIF-1a is degraded in the cytoplasm and is
not typically found in the nucleus. In hypoxia, however,
HIF-1a is accumulated in the cytoplasm and has an overall
increased expression.10,15 A similar effect has previously
been shown when hMSCs are exposed to Co2 + , a hypoxia-
mimicking ion.29,30,36 The hypoxia-mimicking BGs in this
study were able to reproduce these findings (Fig. 4).
We were interested in the effect of the BGs on VEGF,
since it is a HIF-1a-regulated gene and indicates the acti-
vation of the hypoxia response.34 The upregulation of this
growth factor has been shown at both mRNA and protein
levels at various time periods, under a series of different pO2
values, and in various species.9,16,17,19,27,35 VEGF expres-
sion has been shown to be upregulated after exposure to
Co2 + .29,30 Our data are in agreement with these findings,
with the Co2 + -containing BGs enhancing VEGF expression
by hMSCs in a concentration-dependent manner (Fig. 6).
Beyond indicating the activation of the hypoxia pathway,
VEGF is also important in a number of processes essential for
tissue regeneration, for example, the formation of new blood
vessels (vasculogenesis and angiogenesis),37 and has been
used in a number of TE constructs. Biodegradable poly(dl-
lactic acid) scaffolds with encapsulated VEGF and MSCs
were implanted in mouse femur defects for 4 weeks, after
which enhanced bone regeneration, including the synthesis of
new bone matrix was observed.38 A separate study using
VEGF-releasing scaffolds coated with BG showed significant
enhancement of blood vessel density as early as 2 weeks.39
After 12 weeks, the density of mineral bone was also sig-
nificantly enhanced in the VEGF-releasing scaffolds.
In addition to VEGF, the upregulation of other hypoxia-
regulated growth factors critical for angiogenesis (PDGF,
MMP-1, and MMX-1) was detected (Fig. 5). The expression
of many other growth factors known to be enhanced by HIF-
1a under hypoxia (bFGF, HGF, TNF-a, IL-1, and IL-
69,17,28) might also be upregulated by the Co2 + -containing
BGs. However, it is not only the secretion of soluble growth
factors that is increased at low pO2 values but also the in-
creased expression of several membrane receptors involved
in MSC migration and homing to damaged sites, including
CXCR4 and CXCR7, which has been reported in hypoxic
conditions or when cells were exposed to CoCl2.
15 Several
mechanisms critical for tissue regeneration, including an-
giogenesis, migration, and immunomodulatory activity,
could then be enhanced under hypoxia through the trophic
or paracrine activity of MSCs.
Hypoxia has been shown to control and direct progenitor
cell stemness and differentiation through regulation of the
expression of key factors such as Oct4 by HIF-1a.40 This is
also the case for MSCs, where the plasticity and differen-
tiation potential of these progenitor cells have been shown to
be reduced at low pO2 values in most cases.
9,10,11,14,21 Only
the chondrogenic differentiation potential was enhanced
with hypoxia.28 The hypoxia-mimicking BGs could poten-
tially help maintain MSCs in an undifferentiated state in
normoxic conditions through the activation of HIF-1a,
FIG. 6. Effect of hypoxia-mimicking BGs on VEGF ex-
pression. The VEGF concentration was determined using a
VEGF immunoassay after hMSCs were treated with BG-
conditioned media (1.5 mg/mL) for 2, 4, and 7 days. (*) In-
dicates that the difference between the marked bar and the
control (cells cultured with standard cell culture media, with
no BG) for the same time period is statistically significant.
(U) Indicates that the difference between the marked bar and
the sample treated with the dissolution products of BG0Co
for the same time period is statistically significant ( p< 0.05).
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which is essential for ex vivo expansion before implantation
for regenerative therapies, or for promoting differentiation
into the chondrocytic lineage. The effect of BGs on stem
cell (including MSCs) differentiation is still controversial.41
Although several authors have reported BGs to promote
differentiation of MSCs toward an osteogenic lineage,42
others were simply able to show enhanced osteoblastic ac-
tivity.43 Others, however, saw no effect at all of BGs on the
differentiation of MSCs.44 Therefore, it would be interesting
to study the combinatorial effect of the hypoxia-mimicking
BGs on the differentiation potential of hMSCs. Finally,
preconditioning of hMSCs under hypoxia has been shown to
enhance their survival in hypoxic environments, such as
after implantation in cardiac tissue after myocardial infarc-
tion.33,45 The hypoxia-mimicking BGs may then activate
several cellular processes in the hMSCs that are critical to
enhance cell survival and tissue regeneration.
Conclusion
This study shows the activation of the hypoxia pathway in
hMSCs by BGs releasing hypoxia-mimicking Co2 + ions.
Both the expression and activity of HIF-1a were signifi-
cantly enhanced in hMSCs exposed to the hypoxia-mim-
icking BG-conditioned media in a concentration-dependent
manner, independently of the local oxygen pressure. Several
HIF-regulated genes involved in cellular proliferation,
death, metabolism, and differentiation were upregulated in
the same conditions. These results are enticing since various
cellular processes, essential for physiological tissue repair
and regeneration, are activated by the hypoxia pathway. In
particular, our results demonstrate that several genes cru-
cial for angiogenesis were overexpressed, including VEGF
at both the transcript and protein levels, in a concentration-
dependent manner. This simple strategy to stabilize the
hypoxia-sensing transcription factor (HIF-1a) through
the controlled release of ions from BGs is able to induce
the activation of a variety of genes crucial for tissue re-
generation and could be of great potential for use in a
variety of tissue regenerative therapies.
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